StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)

Close on Nov 18, 2026Market cap $104.20MP/E –Yield –

NovaBridge Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

NovaBridge Biosciences's revenue for the twelve months ending Dec 31, 2019 was CN¥30.00M. For fiscal 2023 it was CN¥27.64M. The highest annual figure on record is CN¥1.54B in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023CN¥27.64M–
FY2022Dec 31, 2022-CN¥221.56M-351.7%
FY2021Dec 31, 2021CN¥88.03M-94.3%
FY2020Dec 31, 2020CN¥1.54B+5042.2%
FY2019Dec 31, 2019CN¥30.00M-44.2%
FY2018Dec 31, 2018CN¥53.78M+365.4%
FY2017Dec 31, 2017CN¥11.56M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019CN¥0–

More NovaBridge Biosciences figures

See a number that looks wrong?